PharmaCyte Biotech Inc
pharmacyte.comWhat Do They Do?
Develops cellular cancer therapies using live cells enclosed in cellulose capsules, including a candidate intended for pancreatic tumors.
10-K for FY2026, filed Jul 29, 2026
How Are They Changing?
Narrower therapy focus
The older report described development programs for diabetes and malignant ascites alongside cancer therapies. The latest report focuses on cancer therapies, including work on pancreatic tumors.
10-K for FY2023, filed Jul 31, 2023 10-K for FY2026, filed Jul 29, 2026We are a biotechnology company focused on developing cellular therapies for cancer, diabetes, and malignant ascites based upon a…View ↗
We have also been developing a way to delay the production and accumulation of malignant ascites that results from many types of abdominal…View ↗
We have also been developing a potential therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes. Our product candidate for the…View ↗
Loading...
